AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration Sweden
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions below.